China Pharma plans to launch a therapeutic device for dry eye disease in China

BEIJING (dpa-AFX) – China Pharma Holdings (CPHI) announced that it expects to launch Dry Eye Disease Therapeutic Device in China in the first quarter of 2025 through Hainan Helpson Medical and Biotechnology Co., a wholly-owned subsidiary. It is a medical treatment device for dry eye disease that is under patent protection. The company acquired the technology through Helpson in late 2022.

China Pharma Holdings is a specialty pharmaceutical company that develops, manufactures and markets a diversified product portfolio, focusing on diseases with high incidence and high mortality in China, including cardiovascular diseases, central nervous system diseases, infectious diseases and digestive diseases.

Visit rttnews.com for more health news.

Related Posts

One hotel in Croatia with Waldkindergarten

One of the extreme consequences of this is that nothing happened for a year.

ANALYSIS FLASH: Goldman has Ziel for Broadcom for $190